drugset / Trial / NCT00292370
Quetiapine Augmentation for Treatment-resistant PTSD
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The purpose of this study is to compare the response of veterans with PTSD without an optimal response to paroxetine to quetiapine augmentation versus placebo.
Timeline
- Start
- 2006-01
- Primary completion
- 2008-12
- Completion
- 2009-05
Publications
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Quetiapine | Small molecule | 800 mg | — |
| Background | Paroxetine | Small molecule | 60 mg | — |